BIRC5 and breast carcinoma: Interestingly, we observed that the staining patterns of phosphorylated STAT3, STAT3, and survivin were similar in the serial sections of relapsed HER2-positive breast cancer patients, but not in the recurrence-free patients (Figure 5A and B).